Morgan Stanley Ajinomoto (2802.T): Small Meeting Key Takeaways
Summaries are public. PDF access requires an active membership; all members have the same access. Sign in
Morgan Stanley recently hosted a small meeting with the management team of Ajinomoto (2802.T) to discuss the strategic outlook, capital allocation plans, and segment growth initiatives for the fiscal year 2026, ending March 2027.
Management reaffirmed its operating profit target of 175 billion yen for FY2026, representing approximately 10% year-over-year growth. This expansion is primarily driven by volume and pricing gains within the seasonings and processed foods business. To support long-term expansion, the company plans to increase capital expenditures to 120 billion yen in FY2026, up from 100 billion yen in the prior year, with funds directed toward amino acid and biotechnology capabilities.
Internationally, Ajinomoto expects seasoning sales in Southeast Asia to grow 8%, while frozen food revenue in North America is projected to increase by 12%. Management intends to offset raw material cost inflation through strategic price hikes and product premiumization, targeting a 0.5 percentage point improvement in the gross margin.
The company also remains committed to enhancing shareholder returns, planning a 50 billion yen share buyback for FY2026 while maintaining a dividend of 40 yen per share. Furthermore, management expressed confidence in reaching a 200 billion yen operating profit target by FY2027, bolstered by potential commercialization of pharmaceutical-grade amino acids. No specific mergers and acquisitions targets were discussed.